ID GMHBB_ECOLI Reviewed; 191 AA. AC P63228; P31546; DT 27-SEP-2004, integrated into UniProtKB/Swiss-Prot. DT 27-SEP-2004, sequence version 1. DT 04-NOV-2026, entry version 151. DE RecName: Full=D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase; DE EC=3.1.3.82 {ECO:0000269|PubMed:11751812, ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050614, ECO:0000269|PubMed:20050615, ECO:0000269|PubMed:31449400}; DE AltName: Full=D,D-heptose 1,7-bisphosphate phosphatase; DE Short=HBP phosphatase; GN Name=gmhB; Synonyms=yaeD; OrderedLocusNames=b0200, JW0196; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=K12; RA Miyamoto K., Inokuchi H.; RT "Nucleotide sequence of 5'flanking region of the ribosomal RNA gene (rrnH) RT in E. coli."; RL Submitted (APR-1993) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RA Takemoto K., Mori H., Murayama N., Kataoka K., Yano M., Itoh T., RA Yamamoto Y., Inokuchi H., Miki T., Hatada E., Fukuda R., Ichihara S., RA Mizuno T., Makino K., Nakata A., Yura T., Sampei G., Mizobuchi K.; RT "Systematic sequencing of the Escherichia coli genome: analysis of the 4.0 RT - 6.0 min (189,987 - 281,416bp) region."; RL Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RA Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M., RA Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D., RA Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.; RT "Sequence of minutes 4-25 of Escherichia coli."; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [6] RP FUNCTION AS A HEPTOSE 1,7-BISPHOSPHATE PHOSPHATASE, CATALYTIC ACTIVITY, RP PATHWAY, DISRUPTION PHENOTYPE, AND NOMENCLATURE. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=11751812; DOI=10.1128/jb.184.2.363-369.2002; RA Kneidinger B., Marolda C., Graninger M., Zamyatina A., McArthur F., RA Kosma P., Valvano M.A., Messner P.; RT "Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia RT coli."; RL J. Bacteriol. 184:363-369(2002). RN [7] RP FUNCTION AS A PHOSPHATASE, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE RP SPECIFICITY, COFACTOR, AND PATHWAY. RX PubMed=16990279; DOI=10.1074/jbc.m605449200; RA Kuznetsova E., Proudfoot M., Gonzalez C.F., Brown G., Omelchenko M.V., RA Borozan I., Carmel L., Wolf Y.I., Mori H., Savchenko A.V., Arrowsmith C.H., RA Koonin E.V., Edwards A.M., Yakunin A.F.; RT "Genome-wide analysis of substrate specificities of the Escherichia coli RT haloacid dehalogenase-like phosphatase family."; RL J. Biol. Chem. 281:36149-36161(2006). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, KINETIC PARAMETERS, RP AND PATHWAY. RC STRAIN=K12; RX PubMed=20050615; DOI=10.1021/bi902018y; RA Wang L., Huang H., Nguyen H.H., Allen K.N., Mariano P.S., RA Dunaway-Mariano D.; RT "Divergence of biochemical function in the HAD superfamily: D-glycero-D- RT manno-heptose-1,7-bisphosphate phosphatase (GmhB)."; RL Biochemistry 49:1072-1081(2010). RN [9] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=31449400; DOI=10.1021/acs.biochem.9b00548; RA Huddleston J.P., Raushel F.M.; RT "Biosynthesis of GDP-d-glycero-alpha-d-manno-heptose for the Capsular RT Polysaccharide of Campylobacter jejuni."; RL Biochemistry 58:3893-3902(2019). RN [10] RP X-RAY CRYSTALLOGRAPHY IN COMPLEX WITH DIVALENT CATIONS AND SUBSTRATE RP ANALOGS, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, RP REACTION MECHANISM, SUBUNIT, PATHWAY, DISRUPTION PHENOTYPE, ACTIVE SITE, RP AND MUTAGENESIS OF ASP-11; ASP-13; CYS-107 AND LYS-111. RX PubMed=20050699; DOI=10.1021/bi901780j; RA Taylor P.L., Sugiman-Marangos S., Zhang K., Valvano M.A., Wright G.D., RA Junop M.S.; RT "Structural and kinetic characterization of the LPS biosynthetic enzyme D- RT alpha,beta-D-heptose-1,7-bisphosphate phosphatase (GmhB) from Escherichia RT coli."; RL Biochemistry 49:1033-1041(2010). RN [11] RP X-RAY CRYSTALLOGRAPHY IN COMPLEX WITH SUBSTRATE ANALOGS, CATALYTIC RP ACTIVITY, COFACTOR, SUBUNIT, ACTIVE SITE, AND MUTAGENESIS OF ASP-13; RP CYS-92; CYS-107; CYS-109; ARG-110 AND LYS-137. RX PubMed=20050614; DOI=10.1021/bi902019q; RA Nguyen H.H., Wang L., Huang H., Peisach E., Dunaway-Mariano D., Allen K.N.; RT "Structural determinants of substrate recognition in the HAD superfamily RT member D-glycero-D-manno-heptose-1,7-bisphosphate phosphatase (GmhB)."; RL Biochemistry 49:1082-1092(2010). CC -!- FUNCTION: Converts the D-glycero-beta-D-manno-heptose 1,7-bisphosphate CC (beta-HBP) intermediate into D-glycero-beta-D-manno-heptose 1-phosphate CC by removing the phosphate group at the C-7 position. CC {ECO:0000269|PubMed:11751812, ECO:0000269|PubMed:16990279, CC ECO:0000269|PubMed:20050615, ECO:0000269|PubMed:31449400}. CC -!- CATALYTIC ACTIVITY: CC Reaction=D-glycero-beta-D-manno-heptose 1,7-bisphosphate + H2O = D- CC glycero-beta-D-manno-heptose 1-phosphate + phosphate; CC Xref=Rhea:RHEA:28518, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:60208, ChEBI:CHEBI:61593; EC=3.1.3.82; CC Evidence={ECO:0000269|PubMed:11751812, ECO:0000269|PubMed:16990279, CC ECO:0000269|PubMed:20050614, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:31449400}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050614}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050614}; CC Name=Co(2+); Xref=ChEBI:CHEBI:48828; CC Evidence={ECO:0000269|PubMed:16990279}; CC Note=Magnesium. Can also use other divalent metal cations as manganese CC and cobalt. {ECO:0000269|PubMed:16990279}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000269|PubMed:16990279}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=5 uM for beta-HBP (at pH 7.5 and 25 degrees Celsius) CC {ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:20050699, ECO:0000269|PubMed:31449400}; CC KM=67 uM for alpha-HBP (at pH 7.5 and 25 degrees Celsius) CC {ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:20050699, ECO:0000269|PubMed:31449400}; CC KM=0.2 mM for HBP (at pH 8) {ECO:0000269|PubMed:16990279, CC ECO:0000269|PubMed:20050615, ECO:0000269|PubMed:20050699}; CC KM=0.42 mM for fructose-1,6-bisphosphate (at pH 9) CC {ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:20050699}; CC KM=610 uM for sedoheptulose-1,7-bisphosphate (at pH 7.5) CC {ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:20050699}; CC KM=1501 uM for fructose-1,6-bisphosphate (at pH 7.5) CC {ECO:0000269|PubMed:16990279, ECO:0000269|PubMed:20050615, CC ECO:0000269|PubMed:20050699}; CC Note=kcat is 35.7 sec(-1) and 4.6 sec(-1) with beta-HBP and alpha-HBP CC as substrate, respectively. Thus, the enzyme displays 100-fold more CC efficiency towards the beta- than the alpha-anomer (PubMed:20050615, CC PubMed:31449400). kcat is 0.51 sec(-1) and 0.039 sec(-1) with CC sedoheptulose-1,7-bisphosphate and fructose-1,6-bisphosphate as CC substrate, respectively (PubMed:20050615). CC {ECO:0000269|PubMed:20050615, ECO:0000269|PubMed:31449400}; CC pH dependence: CC Optimum pH is between 6 and 7.5. {ECO:0000269|PubMed:16990279, CC ECO:0000269|PubMed:20050699}; CC -!- PATHWAY: Nucleotide-sugar biosynthesis; ADP-L-glycero-beta-D-manno- CC heptose biosynthesis; ADP-L-glycero-beta-D-manno-heptose from D- CC glycero-beta-D-manno-heptose 7-phosphate: step 2/4. CC {ECO:0000269|PubMed:11751812, ECO:0000269|PubMed:16990279, CC ECO:0000269|PubMed:20050615}. CC -!- PATHWAY: Bacterial outer membrane biogenesis; LPS core biosynthesis. CC {ECO:0000269|PubMed:11751812, ECO:0000269|PubMed:20050699}. CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20050614, CC ECO:0000269|PubMed:20050699}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. CC -!- DISRUPTION PHENOTYPE: Cells lacking this gene result in the formation CC of an altered LPS core, but does not appear to disrupt full-length LPS CC production to an extent that the outer membrane permeability barrier is CC compromised. {ECO:0000269|PubMed:11751812, CC ECO:0000269|PubMed:20050699}. CC -!- MISCELLANEOUS: Phosphatase activity is essential for nucleotide CC activation (fourth step). Zinc ion does not directly participate in CC catalysis, but probably functions to stabilize the loop conformation. CC -!- SIMILARITY: Belongs to the GmhB family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA03661.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D15061; BAA03661.1; ALT_INIT; Genomic_DNA. DR EMBL; U00096; AAC73311.1; -; Genomic_DNA. DR EMBL; AP009048; BAA77877.1; -; Genomic_DNA. DR EMBL; U70214; AAB08628.1; -; Genomic_DNA. DR PIR; H64744; H64744. DR RefSeq; NP_414742.1; NC_000913.3. DR RefSeq; WP_001140187.1; NZ_CP009789.1. DR PDB; 2GMW; X-ray; 1.50 A; A/B=1-191. DR PDB; 3ESQ; X-ray; 1.70 A; A=1-191. DR PDB; 3ESR; X-ray; 1.95 A; A=1-191. DR PDB; 3L1U; X-ray; 1.95 A; A/B=1-191. DR PDB; 3L1V; X-ray; 1.95 A; A/B=1-191. DR PDB; 3L8E; X-ray; 1.64 A; A/B=1-187. DR PDB; 3L8F; X-ray; 1.79 A; A=1-187. DR PDB; 3L8G; X-ray; 2.18 A; A=1-187. DR AlphaFoldDB; P63228; -. DR MDposit; P63228; -. DR SMR; P63228; -. DR BioGRID; 4259752; 293. DR BioGRID; 849279; 4. DR DIP; DIP-47998N; -. DR FunCoup; P63228; 305. DR IntAct; P63228; 11. DR STRING; 511145.b0200; -. DR jPOST; P63228; -. DR PaxDb; 511145-b0200; -. DR EnsemblBacteria; AAC73311; AAC73311; b0200. DR GeneID; 93777223; -. DR GeneID; 944879; -. DR KEGG; ecj:JW0196; -. DR KEGG; eco:b0200; -. DR KEGG; ecoc:C3026_00930; -. DR PATRIC; fig|1411691.4.peg.2078; -. DR EchoBASE; EB1687; -. DR eggNOG; COG0241; Bacteria. DR HOGENOM; CLU_085077_3_0_6; -. DR InParanoid; P63228; -. DR OMA; AACYIER; -. DR OrthoDB; 9781367at2; -. DR PhylomeDB; P63228; -. DR BioCyc; EcoCyc:EG11736-MONOMER; -. DR BioCyc; MetaCyc:EG11736-MONOMER; -. DR BRENDA; 3.1.3.82; 2026. DR UniPathway; UPA00356; UER00438. DR UniPathway; UPA00958; -. DR EvolutionaryTrace; P63228; -. DR PRO; PR:P63228; -. DR Proteomes; UP000000625; Chromosome. DR GO; GO:0005829; C:cytosol; IDA:EcoCyc. DR GO; GO:0034200; F:D-glycero-beta-D-manno-heptose 1,7-bisphosphate 7-phosphatase activity; IDA:UniProtKB. DR GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB. DR GO; GO:0097171; P:ADP-L-glycero-beta-D-manno-heptose biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IBA:GO_Central. DR GO; GO:0009244; P:lipopolysaccharide core region biosynthetic process; IMP:EcoCyc. DR CDD; cd07503; HAD_HisB-N; 1. DR FunFam; 3.40.50.1000:FF:000037; D,D-heptose 1,7-bisphosphate phosphatase; 1. DR Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1. DR InterPro; IPR036412; HAD-like_sf. DR InterPro; IPR006549; HAD-SF_hydro_IIIA. DR InterPro; IPR023214; HAD_sf. DR InterPro; IPR004446; Heptose_bisP_phosphatase. DR InterPro; IPR006543; Histidinol-phos. DR NCBIfam; NF006506; gmhB; 1. DR NCBIfam; TIGR00213; GmhB_yaeD; 1. DR NCBIfam; TIGR01662; HAD-SF-IIIA; 1. DR NCBIfam; TIGR01656; Histidinol-ppas; 1. DR PANTHER; PTHR42891; D-GLYCERO-BETA-D-MANNO-HEPTOSE-1,7-BISPHOSPHATE 7-PHOSPHATASE; 1. DR PANTHER; PTHR42891:SF1; D-GLYCERO-BETA-D-MANNO-HEPTOSE-1,7-BISPHOSPHATE 7-PHOSPHATASE; 1. DR Pfam; PF13242; Hydrolase_like; 1. DR PIRSF; PIRSF004682; GmhB; 1. DR SFLD; SFLDG01134; C1.5.5:_Heptose_Bisphosphate_P; 1. DR SFLD; SFLDG01129; C1.5:_HAD__Beta-PGM__Phosphata; 1. DR SFLD; SFLDS00003; Haloacid_Dehalogenase; 1. DR SUPFAM; SSF56784; HAD-like; 1. PE 1: Evidence at protein level; KW 3D-structure; Carbohydrate metabolism; Cytoplasm; Hydrolase; KW Lipopolysaccharide biosynthesis; Magnesium; Metal-binding; KW Reference proteome; Zinc. FT CHAIN 1..191 FT /note="D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7- FT phosphatase" FT /id="PRO_0000209389" FT ACT_SITE 11 FT /note="Nucleophile" FT /evidence="ECO:0000269|PubMed:20050699" FT ACT_SITE 13 FT /note="Proton donor" FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT BINDING 11..13 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT BINDING 11 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 13 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 19..22 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 53..56 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT BINDING 92 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 94 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 107 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 109 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 110..111 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 136 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 137 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:20050614" FT BINDING 137 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20050614" FT SITE 53 FT /note="Stabilizes the phosphoryl group" FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT SITE 110 FT /note="Contributes to substrate recognition" FT /evidence="ECO:0000269|PubMed:20050614" FT SITE 111 FT /note="Stabilizes the phosphoryl group" FT /evidence="ECO:0000269|PubMed:20050614" FT MUTAGEN 11 FT /note="D->N: Inactive." FT /evidence="ECO:0000269|PubMed:20050699" FT MUTAGEN 13 FT /note="D->A: Inactive." FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT MUTAGEN 13 FT /note="D->N: Inactive." FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT MUTAGEN 92 FT /note="C->A: Reduces the catalytic efficiencies towards the FT alpha and beta-anomers of HBP." FT /evidence="ECO:0000269|PubMed:20050614" FT MUTAGEN 107 FT /note="C->A: More than 3-fold reduction in the affinity FT binding of HBP. Reduces the catalytic efficiencies towards FT the alpha and beta-anomers of HBP." FT /evidence="ECO:0000269|PubMed:20050614, FT ECO:0000269|PubMed:20050699" FT MUTAGEN 109 FT /note="C->A: Reduces the catalytic efficiencies towards the FT alpha and beta-anomers of HBP." FT /evidence="ECO:0000269|PubMed:20050614" FT MUTAGEN 110 FT /note="R->A: Significant reduction in the catalytic FT efficiency of hydrolysis of the physiological substrate FT HBP." FT /evidence="ECO:0000269|PubMed:20050614" FT MUTAGEN 111 FT /note="K->N: Inactive." FT /evidence="ECO:0000269|PubMed:20050699" FT MUTAGEN 137 FT /note="K->A: 8-fold reduction in the affinity binding of FT HBP." FT /evidence="ECO:0000269|PubMed:20050614" FT STRAND 7..10 FT /evidence="ECO:0007829|PDB:2GMW" FT TURN 14..16 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 26..28 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 35..44 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 48..54 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 57..60 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 65..81 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 87..92 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 101..103 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 108..110 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 115..124 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 128..130 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 132..137 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 138..146 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 150..159 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 163..168 FT /evidence="ECO:0007829|PDB:2GMW" FT STRAND 170..174 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 176..178 FT /evidence="ECO:0007829|PDB:2GMW" FT HELIX 179..184 FT /evidence="ECO:0007829|PDB:2GMW" SQ SEQUENCE 191 AA; 21294 MW; E7814B34A23128FA CRC64; MAKSVPAIFL DRDGTINVDH GYVHEIDNFE FIDGVIDAMR ELKKMGFALV VVTNQSGIAR GKFTEAQFET LTEWMDWSLA DRDVDLDGIY YCPHHPQGSV EEFRQVCDCR KPHPGMLLSA RDYLHIDMAA SYMVGDKLED MQAAVAANVG TKVLVRTGKP ITPEAENAAD WVLNSLADLP QAIKKQQKPA Q //